Weiss Multi-Strategy Advisers LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$95,000
-24.0%
27,5000.0%0.00%0.0%
Q2 2018$125,000
-52.7%
27,500
-65.6%
0.00%
-62.5%
Q1 2018$264,000
-59.9%
80,000
-52.7%
0.01%
-52.9%
Q4 2017$659,000
+93.8%
169,034
+238.1%
0.02%
+30.8%
Q1 2017$340,000
-38.2%
50,000
-50.0%
0.01%
-51.9%
Q4 2016$550,000100,0000.03%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders